Patent Assignment
Reel/Frame 038215/0748
Certificate of Change of the Company's Address
Recorded: 2016-03-22
Pages: 2
Assignor
OHR PHARMACEUTICAL, INC.
Executed: 2014-11-14
Assignee
OHR PHARMACEUTICAL, INC.
800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(2)
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 19, 2006
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 018283/0136 →
Assignment of Assignor's Interest
May 9, 2011
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 026246/0796 →
Liquidating Trust Agreement
Mar 16, 2012
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 027874/0365 →
Assignment of Assignor's Interest
Jan 28, 2015
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 034836/0672 →
Assignment of Assignor's Interest
Jan 28, 2015
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 034836/0690 →
Liquidating Trust Agreement
Jan 28, 2015
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 034838/0844 →
Assignment of Assignor's Interest
May 10, 2018
From: OHR PHARMACEUTICAL, INC.
To: ENTERIN, INC.
Reel/Frame 045764/0322 →